PT1047409E - Tts contendo um antioxidante - Google Patents

Tts contendo um antioxidante

Info

Publication number
PT1047409E
PT1047409E PT99902525T PT99902525T PT1047409E PT 1047409 E PT1047409 E PT 1047409E PT 99902525 T PT99902525 T PT 99902525T PT 99902525 T PT99902525 T PT 99902525T PT 1047409 E PT1047409 E PT 1047409E
Authority
PT
Portugal
Prior art keywords
antioxidant
ethyl
tts containing
tts
carbamate
Prior art date
Application number
PT99902525T
Other languages
English (en)
Inventor
Michael Horstmann
Bodo Asmussen
Kai Kopke
Harry Tiemessen
Original Assignee
Lohmann Therapie Syst Lts
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10825116&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT1047409(E) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lohmann Therapie Syst Lts, Novartis Ag filed Critical Lohmann Therapie Syst Lts
Publication of PT1047409E publication Critical patent/PT1047409E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Anti-Oxidant Or Stabilizer Compositions (AREA)
  • Fats And Perfumes (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Dental Preparations (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PT99902525T 1998-01-12 1999-01-08 Tts contendo um antioxidante PT1047409E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9800526.7A GB9800526D0 (en) 1998-01-12 1998-01-12 Organic compounds

Publications (1)

Publication Number Publication Date
PT1047409E true PT1047409E (pt) 2002-12-31

Family

ID=10825116

Family Applications (1)

Application Number Title Priority Date Filing Date
PT99902525T PT1047409E (pt) 1998-01-12 1999-01-08 Tts contendo um antioxidante

Country Status (26)

Country Link
US (1) US6335031B1 (pt)
EP (1) EP1047409B1 (pt)
KR (1) KR100569051B1 (pt)
CN (1) CN1129427C (pt)
AT (1) ATE223711T1 (pt)
AU (1) AU745661B2 (pt)
BR (1) BR9906920A (pt)
CA (1) CA2315784C (pt)
CZ (1) CZ300598B6 (pt)
DE (1) DE69902875T2 (pt)
DK (1) DK1047409T3 (pt)
ES (1) ES2184408T3 (pt)
GB (1) GB9800526D0 (pt)
HK (1) HK1034036A1 (pt)
HU (1) HU227159B1 (pt)
ID (1) ID27503A (pt)
IL (1) IL137100A (pt)
MX (1) MXPA00006438A (pt)
NO (1) NO328390B1 (pt)
NZ (1) NZ505650A (pt)
PL (1) PL201328B1 (pt)
PT (1) PT1047409E (pt)
RU (1) RU2219926C2 (pt)
SK (1) SK284622B6 (pt)
TR (2) TR200001688T2 (pt)
WO (1) WO1999034782A1 (pt)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69923200T2 (de) * 1998-10-01 2005-12-22 Novartis Ag Neue oral anzuwendende arzneizubereitungen für rivastigmine mit kontrollierter wirkstoffabgabe
FR2793689B1 (fr) * 1999-05-19 2001-08-24 Pf Medicament Dispositif transdermique pour l'administration de testosterone ou d'un de ses derives
RU2266735C2 (ru) * 1999-11-29 2005-12-27 Лтс Ломанн Терапи-Системе Аг Трансдермальные терапевтические системы с повышенной стабильностью и способ их получения
DE10107663B4 (de) * 2001-02-19 2004-09-09 Lts Lohmann Therapie-Systeme Ag Testosteronhaltiges transdermales therapeutisches System, Verfahren zu seiner Herstellung und seine Verwendung
ITMI20020798A1 (it) * 2002-04-15 2003-10-15 F T Holding S A Cerotti transdermici a matrice adesiva siliconica stabilizzati con copolimeri metacrilici
FR2881653A1 (fr) * 2005-02-04 2006-08-11 Frederic Khodja Dispositif permettant l'administration en continu d'une dose physiologique controlee d'au moins un mineral ou une vitamine
TWI389709B (zh) * 2005-12-01 2013-03-21 Novartis Ag 經皮治療系統
WO2009022345A1 (en) * 2007-08-14 2009-02-19 Yissum Research Development Company Of The Hebrew University Of Jerusalem Phenyl carbamates for the treatment of multiple sclerosis
PE20110591A1 (es) 2008-07-28 2011-09-15 Takeda Pharmaceutical Composicion farmaceutica estabilizada a base de un compuesto no peptidico
US20100087768A1 (en) * 2008-10-02 2010-04-08 Forlano Paula Transdermal drug delivery system for liquid active ingredient
US10076502B2 (en) 2009-12-22 2018-09-18 Luye Pharma Ag Transdermal therapeutic system for administering rivastigmine or derivatives thereof
JP6083734B2 (ja) 2009-12-22 2017-02-22 リュイェ ファーマ アーゲーＬｕｙｅ Ｐｈａｒｍａ ＡＧ リバスチグミンまたはその誘導体を投与するための経皮治療システム
ES2363395B1 (es) * 2010-01-20 2012-02-23 Farmalider, S.A. Composición farmacéutica l�?quida de rivastigmina o de una de sus sales de adición de �?cido para la administración por v�?a oral.
WO2011151359A1 (en) 2010-06-02 2011-12-08 Noscira, S.A. Combined treatment with a cholinesterase inhibitor and a thiadiazolidinedione derivative
DE102010026903A1 (de) 2010-07-12 2012-01-12 Amw Gmbh Transdermales therapeutisches System mit Avocadoöl oder Palmöl als Hilfsstoff
SG10201505658RA (en) 2010-07-21 2015-09-29 3M Innovative Properties Co Transdermal adhesive compositions, devices, and methods
ES2545094T3 (es) * 2010-12-14 2015-09-08 Acino Ag Sistema terapéutico transdérmico para la administración de un principio activo
KR101788802B1 (ko) * 2010-12-24 2017-10-20 주식회사 삼양바이오팜 리바스티그민을 함유하는 경피흡수제제
KR20120126898A (ko) * 2011-05-13 2012-11-21 에스케이케미칼주식회사 리바스티그민 또는 이의 염을 함유하는 경피 투여 조성물
KR20120130073A (ko) * 2011-05-20 2012-11-28 에스케이케미칼주식회사 리바스티그민 함유 패취
WO2012161489A2 (ko) 2011-05-20 2012-11-29 에스케이케미칼 주식회사 리바스티그민 함유 패취
EP2594261A1 (en) 2011-11-18 2013-05-22 Labtec GmbH Composition for transdermal administration of rivastigmine
DE102012000369A1 (de) 2012-01-11 2013-07-11 Alfred E. Tiefenbacher (Gmbh & Co. Kg) Transdermales therapeutisches System mit Cholinesterase-Hemmer
WO2013142339A1 (en) 2012-03-23 2013-09-26 Novartis Ag Transdermal therapeutic system and method
JP6153135B2 (ja) 2012-06-12 2017-06-28 株式会社 ケイ・エム トランスダーム 貼付剤
EP2893927A4 (en) * 2012-09-03 2016-03-09 Nipro Patch Co Ltd SKIN PATCH
KR20140038237A (ko) 2012-09-20 2014-03-28 에스케이케미칼주식회사 리바스티그민의 안정성이 개선된 의약품
WO2014051128A1 (ja) 2012-09-28 2014-04-03 株式会社 ケイ・エム トランスダーム 貼付剤
WO2014111790A2 (en) 2013-01-15 2014-07-24 Zydus Technologies Limited Stable transdermal pharmaceutical drug delivery system comprising rivastigmine
CN106413695B (zh) * 2014-04-08 2019-12-10 帝国制药美国公司 利伐斯的明透皮组合物及其使用方法
JPWO2015174502A1 (ja) 2014-05-15 2017-05-25 ニチバン株式会社 リバスチグミンを含有する貼付剤のための包装体
KR20200025883A (ko) 2018-08-31 2020-03-10 에스케이케미칼 주식회사 장기 투여용 리바스티그민 패취
KR20200025888A (ko) 2018-08-31 2020-03-10 에스케이케미칼 주식회사 장기 투여용 리바스티그민 패취

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL195004C (nl) * 1987-03-04 2003-11-04 Novartis Ag Fenylcarbamaat bevattend farmaceutisch preparaat.
AU5716898A (en) * 1997-01-08 1998-08-03 Warner-Lambert Company Acetylcholinesterase inhibitors in combination with muscarinic agonists for the treatment of alzheimer's disease
EP0952826B1 (en) * 1997-01-17 2001-11-14 Takeda Chemical Industries, Ltd. Idebenone containing combination agent for treating alzheimer's disease

Also Published As

Publication number Publication date
SK10532000A3 (sk) 2000-11-07
AU2278599A (en) 1999-07-26
ID27503A (id) 2001-04-12
KR20010033072A (ko) 2001-04-25
HUP0004300A3 (en) 2003-05-28
CA2315784C (en) 2006-06-27
MXPA00006438A (es) 2003-07-21
ES2184408T3 (es) 2003-04-01
HUP0004300A2 (hu) 2001-05-28
CA2315784A1 (en) 1999-07-15
DK1047409T3 (da) 2002-12-30
AU745661B2 (en) 2002-03-28
DE69902875D1 (de) 2002-10-17
WO1999034782A1 (en) 1999-07-15
NO20003472L (no) 2000-08-07
CN1288375A (zh) 2001-03-21
RU2219926C2 (ru) 2003-12-27
HK1034036A1 (en) 2001-10-12
EP1047409B1 (en) 2002-09-11
SK284622B6 (sk) 2005-08-04
US6335031B1 (en) 2002-01-01
CZ300598B6 (cs) 2009-06-24
PL341347A1 (en) 2001-04-09
IL137100A0 (en) 2001-06-14
GB9800526D0 (en) 1998-03-11
DE69902875T2 (de) 2003-05-22
IL137100A (en) 2004-12-15
NO20003472D0 (no) 2000-07-05
HU227159B1 (en) 2010-09-28
PL201328B1 (pl) 2009-03-31
ATE223711T1 (de) 2002-09-15
KR100569051B1 (ko) 2006-04-10
TR200101021T2 (tr) 2002-06-21
JP2002500178A (ja) 2002-01-08
EP1047409A1 (en) 2000-11-02
CZ20002557A3 (cs) 2000-10-11
BR9906920A (pt) 2000-10-10
NO328390B1 (no) 2010-02-08
JP3820103B2 (ja) 2006-09-13
NZ505650A (en) 2002-10-25
CN1129427C (zh) 2003-12-03
TR200001688T2 (tr) 2000-11-21

Similar Documents

Publication Publication Date Title
PT1047409E (pt) Tts contendo um antioxidante
BG66093B1 (bg) Състави с контролирано освобождаване, съдържащи нимесулид
BR0008590A (pt) Agente de entrega polimérico, composição, formade unidade de dosagem, método para administrarum agente biologicamente ativo a um animalnecessitando o agente, método para preparar umacomposição; e composto
AR037081A1 (es) Composicion para el suministro transdermico de fentanilo
ATE383849T1 (de) Transdermale pharmazeutische zusammensetzung
ATE493973T1 (de) Irbesartan enthaltende pharmazeutische zusammensetzung
ATE288256T1 (de) Dermale zusammensetzungen
TR200100812T2 (tr) Akut ağrı tedavisi için fentanil kompozisyon.
ATE249422T1 (de) Verbindungen und zusammensetzungen zur verabreichung aktiver stoffe
ATE324907T1 (de) Verbindung und arzneizusammensetzung zur verabreichung von wirkstoffen
FI962770A0 (fi) Transdermaalinen laite, joka sisältää polyvinyylipyrrolidonia liukoisuutta parantavana aineena
ATE245450T1 (de) Haftende mikrokügelchen umfassende zusammensetzung zur arzneimittelgabe
DE60036807D1 (de) Verfahren zur herstellung eines pharmazeutischen kaugummis
CO5640120A2 (es) Formulacion y metodods para el tratamiento de trombocitemia
DK1303278T3 (da) Kombination af et transdermalt terapeutisk system og et oralt og/eller parenteralt præparat indeholdende dopaminagonister til behandling af dopaminerge sygdomme
HRP20080178T3 (en) Pharmaceutical composition in the form of a hydrogel for transdermal administration of active substances
TR200400241T4 (tr) Lasofoksifen'in transdermal olarak verilmesi
EP1300143A4 (en) STAMP CONTAINING 4-BIPHENYLACETIC ACID
BR9911960A (pt) Composição medicamentosa autoadesiva, e utilização da mesma
ATE102934T1 (de) Fluorierte flavon-essigsaeure.